Colgate-Palmolive (NYSE:CL) Shares Bought by Driehaus Capital Management LLC

Driehaus Capital Management LLC grew its position in shares of Colgate-Palmolive (NYSE:CL) by 63.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,294 shares of the company’s stock after acquiring an additional 4,792 shares during the quarter. Driehaus Capital Management LLC’s holdings in Colgate-Palmolive were worth $1,193,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of CL. Stonehage Fleming Financial Services Holdings Ltd lifted its holdings in Colgate-Palmolive by 57.1% during the 4th quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock worth $30,594,000 after buying an additional 139,429 shares during the last quarter. D L Carlson Investment Group Inc. acquired a new position in shares of Colgate-Palmolive in the 4th quarter worth $3,269,000. Diversify Advisory Services LLC acquired a new position in shares of Colgate-Palmolive in the 1st quarter worth $911,000. TD Asset Management Inc grew its holdings in shares of Colgate-Palmolive by 2.4% in the 1st quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock worth $103,969,000 after acquiring an additional 26,987 shares during the last quarter. Finally, Empowered Funds LLC boosted its position in shares of Colgate-Palmolive by 277.3% in the first quarter. Empowered Funds LLC now owns 33,082 shares of the company’s stock worth $2,979,000 after buying an additional 24,314 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Buying and Selling

In other Colgate-Palmolive news, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the sale, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the transaction, the executive vice president now owns 10,377 shares of the company’s stock, valued at $1,069,868.70. The disclosure for this sale can be found here. Over the last three months, insiders have sold 43,490 shares of company stock worth $4,486,063. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Trading Up 0.6 %

NYSE CL opened at $103.66 on Monday. The business has a 50 day simple moving average of $103.25 and a 200 day simple moving average of $96.42. Colgate-Palmolive has a one year low of $67.62 and a one year high of $109.30. The stock has a market capitalization of $85.05 billion, a P/E ratio of 32.80, a P/E/G ratio of 3.62 and a beta of 0.40. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. During the same quarter last year, the firm posted $0.77 earnings per share. The company’s revenue for the quarter was up 4.9% compared to the same quarter last year. Research analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.93%. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Analyst Ratings Changes

A number of research firms recently issued reports on CL. Jefferies Financial Group cut Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price objective for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their target price for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Citigroup boosted their price objective on Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Morgan Stanley boosted their price objective on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Finally, Wells Fargo & Company downgraded Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 price objective for the company. in a report on Monday, September 16th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $104.74.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.